Blog
903 Articles
What Is It Going to Take to Stop Pancreatic Cancer? A 10-Year Survivor’s Perspective
Survivor William Ramshaw reflects on the need for more research into treatments and early detection tests for pancreatic cancer.
Hope is Everything You Have
Long-term survivor Eric Borden believes in the importance of advocating for yourself with your doctors; if he hadn’t he might not be here.
More Research Needed For Neuropathy
Dr. Allyson Ocean discusses the use of glutamine to ease the neuropathy caused by chemotherapy drugs for pancreatic cancer.
Focus on Joy
Long-term survivor Marisa Harris shares her thoughts on surviving, thriving, and making the most of your time while in treatment.
A New Treatment for Progressive Metastatic Pancreatic Cancer
Researchers are testing a new drug for second-line therapy (after initial treatment stops working) in metastatic pancreatic cancer.
AI Platform Reveals Hidden Biology of Tumor Formation
Dr. Laura Wood and colleagues are developing an artificial intelligence (AI) platform to identify tumors as they are forming.
Vigilance in Pursuing Symptoms Leads to Early Diagnosis
Jay Buth was very persistent in pursuing the reason for his symptoms. That led to a diagnosis of early stage pancreatic cancer.
Integrative Oncology Explained
Dr. Santosh Rao believes in the value of integrative oncology, which treats the whole person, not just the patient.
Own Your Health Care Journey
Randi Ervin is a long-term survivor of PNET who stresses the importance of taking care of your mental health during ongoing treatment.
New Potential Early Detection Trial for Type 2 Diabetics
Dr. Anna Bergamaschi explains the new Avantect blood test for the early detection of pancreatic cancer in people with type 2 diabetes.
Reeducating Myself About Pancreatic Cancer
Martin Hynes knew all about pancreatic cancer–as a research director he worked on the development of Gemzar. He was able to have a Whipple and is doing well.
Brain Cancer Vaccine for Metastatic PNET
Researchers are testing a vaccine for PNET that targets a protein that is very abundant in many neuroendocrine tumors.
PRECEDE Trial Sets Survival Rate Goal
Dr. Raymond Wadlow explains how earlier detection of high-risk people is key the PRECEDE trial’s goal to increase pancreatic cancer survival rates.
Using Humor to Face Pancreatic Cancer
Richard Liles has a stage IV pancreatic cancer diagnosis but feels it is very important to keep a sense of humor throughout.
I’m a Person, Not a Diagnosis
Burt Rosen discusses his life with PNET, making sure he is a person, and more than his diagnosis.